Pictet Asset Management Holding SA
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1993888
CAROUGE, V8
Position in TRVI
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$20,353,152
+$1,172,350 QoQ
Shares Held
1,706,048
+11.4% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 90.15033574670818.ToString("F0")%
Shared 0.ToString("F0")%
None 9.849664253291818.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $3,316,428,809 across 130 Biotechnology names. TRVI ranks #51 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
337,254 | $260,575,930 | |
| 2 | INSM |
INSMED Inc
|
1,102,248 | $180,239,592 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
337,569 | $150,738,061 | |
| 4 | ARGX |
Argenx SE
|
148,306 | $108,300,456 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,434,995 | $107,753,774 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
1,381,184 | $102,566,723 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
187,240 | $98,014,522 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
286,644 | $92,353,830 |
All Filings in TRVI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,353,152 | 1,706,048 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $19,180,802 | 1,532,013 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $103,019 | 11,259 | Shares | Sole | 2025-11-18 | |
| No filing history on record for this holder in this stock. | ||||||